Nab-paclitaxel for breast cancer: a new formulation with an improved safety profile and greater efficacy.
about
Tubulin-interactive natural products as anticancer agentsTargeted chemotherapy with nanoparticle albumin-bound paclitaxel (nab-paclitaxel) in metastatic breast cancer: which benefit for which patients?Targeted nanoparticles that deliver a sustained, specific release of Paclitaxel to irradiated tumors.Synergy of nab-paclitaxel and bevacizumab in eradicating large orthotopic breast tumors and preexisting metastases.A phase II evaluation of nanoparticle, albumin-bound (nab) paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer: a Gynecologic Oncology Group study.Synthesis and biological evaluation of a peptide-paclitaxel conjugate which targets the integrin αvβ₆Nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as second-line chemotherapy in HER2-negative, taxane-pretreated metastatic breast cancer patients: prospective evaluation of activity, safety, and quality of life.Phase II trial of nab-paclitaxel in the treatment of recurrent or persistent advanced cervix cancer: A gynecologic oncology group studyMultifunctional synthetic poly(L-glutamic acid)-based cancer therapeutic and imaging agents.Nab-paclitaxel efficacy in the orthotopic model of human breast cancer is significantly enhanced by concurrent anti-vascular endothelial growth factor A therapy.Advances in the treatment of breast cancer.Design, synthesis and applications of hyaluronic acid-paclitaxel bioconjugates.Environmentally responsive peptides as anticancer drug carriers.Cisplatin improves antitumor activity of weekly nab-paclitaxel in patients with metastatic breast cancer.Safety and efficacy evaluation of albumin-bound paclitaxel.Tumor aerobic glycolysis: new insights into therapeutic strategies with targeted delivery.Current strategies for targeted delivery of bio-active drug molecules in the treatment of brain tumor.Nanoparticle-based drug delivery systems: a commercial and regulatory outlook as the field matures.Preclinical evaluation of nanoparticle albumin-bound paclitaxel for treatment of pediatric bone sarcoma.Incorporation of lapatinib into lipoprotein-like nanoparticles with enhanced water solubility and anti-tumor effect in breast cancer.Systemic administration of polymeric nanoparticle-encapsulated curcumin (NanoCurc) blocks tumor growth and metastases in preclinical models of pancreatic cancer.In vivo characterization of a polymeric nanoparticle platform with potential oral drug delivery capabilities.Role of nab-paclitaxel in metastatic breast cancer: a meta-analysis of randomized clinical trials.A Phase I/II Study of Nab-Paclitaxel, Cisplatin, and Cetuximab With Concurrent Radiation Therapy for Locally Advanced Squamous Cell Cancer of the Head and Neck.
P2860
Q24650163-34F38894-D6B5-46E6-B9C7-E02113F4610CQ26745420-26108E54-A137-4E8E-9D59-09972D7B824DQ33891952-C9C4CAD5-3181-49FC-9B71-4F74F47246C7Q34763649-2F740C99-0ABC-4648-9F39-782342345A57Q35013760-8B34E8AD-BF03-44BD-826D-A4BB08A9C3EFQ35368323-52BAE8BB-EF95-4323-B0AC-8EAAA4ED2CD5Q35507680-3DB0F706-00FF-4AC2-8839-8399CFF3BD6BQ35695168-8D330208-9C9F-4D81-AD3A-8995EEE70829Q36214907-7AE976C1-0D6B-4D9F-AC8B-A8B55CE902B8Q36661727-375BF37F-FAD7-4C71-BAF1-6777B9DDA66EQ37037373-21997F8A-4B86-47EC-BEE5-8E73D6F4B053Q37096500-D39DD2F4-11A3-47EA-B0AA-F972D2F67976Q37560183-EF9A9FF3-DF7B-4F9C-9244-703583665E56Q37659713-A962EFB4-7832-4BBF-9F63-1432F6464600Q38190090-A8790EED-FEBD-4427-8805-431DEA7D397AQ38206826-7DE4B26D-7786-4611-9C83-A470DD0C880BQ38401892-D597A8E6-8F0E-4125-B786-6D425B3CA34FQ38978632-0109BD3B-79C9-494E-981D-E2E2DA12951DQ39002209-DEA1DD91-412A-4DEE-8DF5-5E034E26BF61Q39186813-14C08A0E-D6A6-4D02-A2D6-4AA2EA9AD979Q39677752-02FAFB67-4B4C-4C4C-9B6F-692615254199Q39906054-3509005E-3371-4E19-8528-95A9BA64C5FCQ42700716-A549017B-488F-4864-969E-CAD6D5E0F806Q47253569-31D2BB40-6397-47A9-9853-C1561874BD97
P2860
Nab-paclitaxel for breast cancer: a new formulation with an improved safety profile and greater efficacy.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Nab-paclitaxel for breast canc ...... profile and greater efficacy.
@en
type
label
Nab-paclitaxel for breast canc ...... profile and greater efficacy.
@en
prefLabel
Nab-paclitaxel for breast canc ...... profile and greater efficacy.
@en
P2860
P356
P1476
Nab-paclitaxel for breast canc ...... profile and greater efficacy.
@en
P2093
I Craig Henderson
Vinona Bhatia
P2860
P304
P356
10.1586/14737140.7.7.919
P577
2007-07-01T00:00:00Z